Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Feb;16(1):250-255.
doi: 10.1111/iwj.13019. Epub 2018 Nov 4.

Non-uraemic calciphylaxis successfully treated with pamidronate infusion

Affiliations
Case Reports

Non-uraemic calciphylaxis successfully treated with pamidronate infusion

David H Truong et al. Int Wound J. 2019 Feb.

Abstract

Calciphylaxis is a rare and potentially fatal disease that affects the subcutaneous layer of the skin. It is a calcific vasculopathy induced by a systemic process that causes occlusion of small blood vessels. The mortality rate for individuals diagnosed with calciphylaxis is estimated between 52% and 81% with sepsis being the leading cause of death. Uraemic calciphylaxis and its known effective treatments are well documented in the literature. Unfortunately, there is no known effective treatment for non-uraemic calciphylaxis. Most of the current treatments for non-uraemic calciphylaxis are derived from uraemic calciphylaxis treatment protocols. We report a case of a 75-year-old female with calciphylaxis on the right lower extremity who was successfully treated with four pamidronate infusions in addition to local wound care. This case represents a non-uraemic calciphylaxis wound successfully treated with pamidronate infusions and standard wound care, and suggests that IV pamidronate can be an effective treatment option.

Keywords: calcific arteriolopathy; leg ulcer; non-healing wound; sodium thiosulphate; vascular calcifications.

PubMed Disclaimer

Conflict of interest statement

Disclosure

None reported.

Figures

Figure 1
Figure 1
Initial presentation of right lower extremity wounds—Oedematous with multiple discoloured crusted lesions with violaceus borders on the posterior, medial, and lateral aspect of the right distal leg
Figure 2
Figure 2
One month after initial presentation. The wound had worsened with an eschar developed over the crusted lesion along increased pain
Figure 3
Figure 3
Right lower extremity wounds 3 months after initial presentation. The discoloured lesions had transformed into extremely tender reticulate purpura with black eschar and violaceous borders
Figure 4
Figure 4
Histology of right lower extremity wound. The specimen shows small vessels in the interlobular septa and at the periphery of a lobule that show some calcific deposits in the vessel walls. One of the superficial dermal‐dilated small vessels contains a small amount of fibrin thrombus. A von Kossa stain for calcium was carried out and fine granular calcific deposits were found in the vessels in the dermal subcutaneous layer and in smaller capillary size vessels in the superficial subcutaneous tissue
Figure 5
Figure 5
Four months since treatment started. Two weeks status post the first pamidronate infusion. The eschars had almost completely resolved with improvement in ulcer size and wound base appearance
Figure 6
Figure 6
After third infusion of pamidronate. The eschars and fibrotic wounds base had completely resolved. Epithelisation was noted with improvement in wound size and pain
Figure 7
Figure 7
After fourth pamidronate infusion. Wounds had completely closed
Figure 8
Figure 8
One month since the last pamidronate infusion. The wound remained closed
Figure 9
Figure 9
Suggested initial treatment guideline for non‐uraemic calciphylaxis (NUC). Once etiology is determined, treatment of the underlying condition is recommended

Similar articles

Cited by

References

    1. Ning MS, Dahir KM, Castellanos EH, McGirt LY. Sodium thiosulfate in the treatment of non‐uremic calciphylaxis. J Dermatol. 2013;40(8):649‐652. - PubMed
    1. Vicco MH, Ferini F, Rodeles L, Baretta M, Marcipar I, Bottasso OA. Non‐uremic calciphylaxis and chagas disease. Rev Clin Esp (Barc). 2014;214(5):55. - PubMed
    1. Nigwekar SU. Multidisciplinary approach to calcific uremic arteriolopathy. Curr Opin Nephrol Hypertens. 2015;24(6):531‐537. - PubMed
    1. Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008;3(4):1139‐1143. - PMC - PubMed
    1. Nigwekar SU, Kroshinsky D, Nazarian RM, et al. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015;66(1):133‐146. - PMC - PubMed

Publication types

Substances